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Three recent papers provide new insights into endocrinology in the worm Caenorhabditis 
elegans. These studies identify natural steroid ligands for the DAF-12 nuclear receptor, 
define a new enzyme in the hormone biosynthetic pathway, and clarify the role of endocrine 
signaling in adult longevity.Many animals rely on some form of diapause to cope with 
difficult environmental circumstances, allowing them to 
survive until conditions improve and they can return to nor-
mal reproductive life. Diapause may seem to be a develop-
mental anomaly in a life cycle; however, detailed genetic 
studies in the nematode worm Caenorhabditis ­ elegans 
have shown that this is not the case. Rather, the regula-
tion of C. ­elegans diapause has provided key insights into 
the progression of normal postembryonic development—
growth, sexual maturation, and senescence—critical 
steps in the life cycle of higher organisms.
Increased temperature, crowding, or nutritional deple-
tion during the early stages of C. ­ elegans development 
leads to the formation of an alternate third larval stage, the 
dauer larva, which is specially adapted for long-term sur-
vival. Upon a return to favorable conditions, the dauer larva 
emerges from diapause, resumes feeding, and continues 
to develop into an adult with a normal life span. Detailed 
studies have defined a genetic circuit that relays cues 
from chemosensory neurons to signal-transduction path-
ways that direct the choice between normal reproductive 
development and the dauer diapause. These studies arose 
from screens for mutants defective in their ability to form 
dauer larvae (Daf-d) or mutants that form constitutive dau-
ers under favorable conditions (Daf-c; Riddle and Albert, 
1997). Epistasis tests placed these genes in a pathway, 
with parallel input from TGF-β and insulin/IGF (insulin-like 
growth factor) signaling. This regulation makes sense as 
it is critical for the animal to properly assess its nutritional 
status prior to entering the prolonged period of diapause. 
During normal development, the DAF-2 insulin receptor 
acts through an evolutionarily conserved PI 3-kinase/AKT 
pathway to phosphorylate the transcription factor DAF-
16, the worm ortholog of FOXO. This prevents DAF-16 
translocation to the nucleus and allows normal growth to 
proceed (Figure 1A). In unfavorable environments, insulin/
IGF signaling becomes inactive, and dephosphorylated 
DAF-16 is translocated to the nucleus where it blocks 
growth and directs dauer formation (Figure 1B). Similarly, 
in unfavorable conditions, the TGF-β ligand DAF-7 acts 
through the type II TGF-β receptor DAF-4 to regulate the 
downstream effectors DAF-3 (SMAD) and DAF-5 (SKI/
SNO), promoting dauer formation. These parallel insulin 
and TGF-β signaling inputs act in a cell nonautonomous manner to control reproductive growth and converge on 
two genes at the end of the pathway, daf-9 and daf-12, 
with daf-9 acting upstream from daf-12.
An Endocrine Model for Reproductive Growth
The identification of daf-9 as encoding a CYP2 cyto-
chrome P450 enzyme and daf-12 as encoding a nuclear 
hormone receptor, provided a mechanism for the cell 
nonautonomous relay of insulin and TGF-β inputs (Antebi 
et al., 2000; Gerisch et al., 2001; Jia et al., 2002; Mak and 
Ruvkun, 2004). Based on the ability of mammalian CYP2 
enzymes to metabolize steroid hormones and the iden-
tification of steroid-hormone ligands for the vertebrate 
orthologs of DAF-12, an endocrine signaling model was 
proposed in which a hormone from DAF-9 is received 
by DAF-12 to direct reproductive growth (Figure 1A). 
In unfavorable conditions, DAF-9 was proposed to be 
inactive, leading to a presumed repressive function for the 
unliganded DAF-12, directing the dauer fate (Figure 1B).
Several lines of evidence support this model. First, daf-9 
acts nonautonomously and is expressed in endocrine cells 
or tissues that include the hypodermis, spermatheca, and a 
pair of cells located in a head ganglion (Gerisch and Antebi, 
2004; Jia et al., 2002; Mak and Ruvkun, 2004), whereas 
DAF-12 is widely expressed, consistent with its role in 
executing multiple developmental programs (Antebi et al., 
2000). Second, the phenotypes of daf-9 mutants resemble 
daf-12 mutants that map to critical DAF-12 amino acids that 
are predicted to act as hormone contact sites (Gerisch et 
al., 2001; Jia et al., 2002). Third, cholesterol deprivation 
mimics daf-9 and daf-12 mutations and leads to a few ani-
mals that form dauer-like larvae (Gerisch et al., 2001; Jia et 
al., 2002; Matyash et al., 2004). Fourth, mutations in ncr-
1 and ncr-2, homologs of the human Niemann-Pick type 
C gene that are required for proper cholesterol trafficking 
in C. ­ elegans, form transient dauer larvae that resemble 
cholesterol-deprived animals (Li et al., 2004). Finally, crude 
lipid extracts can rescue daf-9 mutant phenotypes as well 
as the dauers that form in the absence of dietary choles-
terol (Gill et al., 2004; Matyash et al., 2004). Taken together, 
these lines of evidence provide strong support for DAF-9 
and DAF-12 acting in an endocrine signaling pathway that 
regulates postembryonic development.Cell 124, March 24, 2006 ©2006 Elsevier Inc. 1137
Figure 1. Regulation of Reproductive Growth, Dauer Formation, and Increased Longevity Due to Germline Ablation in the Worm
(A) Blue indicates that the factor is active; red indicates inactive. In favorable conditions, insulin signaling through the DAF-2 receptor re-
stricts the DAF-16 FOXO transcription factor to the cytoplasm, promoting reproductive growth of the worm C. ­ elegans. Active TGF-β signal-
ing through the DAF-4 receptor inhibits the DAF-3 SMAD. In response to these parallel inputs, the DAF-36 Rieske-like oxygenase and DAF-
9 cytochrome P450 enzyme produce dafachronic acid ligands that activate the DAF-12 nuclear receptor, directing reproductive growth. 
(B) In unfavorable conditions, DAF-16 translocates to the nucleus where it regulates genes that block growth. DAF-9 is inactive under these condi-
tions, with the unliganded DAF-12 acting as a repressor. Only the parallel and upstream functions of DAF-2 are depicted in (A) and (B) for simplicity. 
(C) DAF-9, DAF-12, and KRI-1 act through DAF-16 to extend the life span of germline-deficient animals. Although it is likely that DAF-36 acts up-
stream of DAF-9 in this pathway, no studies have been done to place DAF-36 in this pathway.Temporal Identity and Aging: DAF-9 and DAF-12
Reproductive growth also involves the proper temporal 
progression of development in the third and fourth larval 
stages. This is reflected by the incorrect coordination of 
developmental programs in some daf-12 mutants, giving 
phenotypes that are referred to as heterochronic because 
of their effects on developmental timing (Antebi et al., 2000). 
In addition, the DAF-9/DAF-12 pathway regulates longevity 
during adult stages. Germline ablation of C. ­elegans results 
in up to a 60% increase in adult longevity (Hsin and Ken-
yon, 1999). This is not due to sterility as removal of both the 
germline and somatic gonad does not lead to an extended 
adult life span. In addition, the link between the germline 
and adult longevity is not unique to worms because simi-
lar effects have been seen in Drosophila and mice (Ken-
yon, 2005). This coupling could have beneficial effects for 
survival of the species by allowing the animal to adjust its 
aging in response to its ability to reproduce. The effect of 
germline ablation on life span goes through the DAF-16 
transcription factor which mediates the output of insulin/
IGF and, presumably, other signaling pathways (Hsin and 
Kenyon, 1999; Kenyon, 2005; Tatar et al., 2003; Figure 1C). 
One of these pathways is associated with daf-9 and daf-12, 
which appear to act together with daf-16 to modulate the 
effects on life span seen in germline-deficient animals. The 
exact nature of these interactions remains unclear.
Endocrine Model Confirmed: Ligands for DAF-12
Motola et al. (2006) usher in the age of C. ­ elegans 
molecular endocrinology by identifying the first steroid 
hormones in this organism—the much-awaited ligands 
for the DAF-12 nuclear receptor. They exploit the past 
studies of DAF-9 and DAF-12, using the enzyme and 
receptor as tools to identify small chemical compounds 
that link one with the other. Their initial screen showed 1138 Cell 124, March 24, 2006 ©2006 Elsevier Inc.that 3-keto-lithocholic acid, but not lithocholic acid, 
weakly activates DAF-12 in a tissue culture cotransfec-
tion assay, independently of coexpressed DAF-9. The 
identification of a C-3 ketone suggested that 3-keto-
sterols may function as DAF-12 ligands. This hypothesis 
was confirmed by showing that two naturally occur-
ring 3-keto sterols—4-cholesten-3-one (an oxidation 
product of cholesterol) and lathosterone (a C. ­elegans 
cholesterol metabolite)—could activate DAF-12 in the 
presence, but not the absence, of DAF-9. In addition, 
either 4-cholesten-3-one or lathosterone that had been 
incubated with microsomes containing DAF-9 resulted 
in a complete rescue of daf-9 null mutants. This rescue 
was dependent upon using 3-keto-sterols as precursors 
and having DAF-9 in the microsomes.
Further analysis of the DAF-9 metabolites of 4-cho-
lesten-3-one and lathosterone identified these com-
pounds as 3-keto-4-cholestenoic acid and 3-keto-
7,(5α)-cholestenoic acid, respectively. The observation 
that these compounds are 3-keto, C-26 oxidized deriva-
tives of cholesterol is consistent with biochemical stud-
ies of DAF-9, which showed that it acts as a 3-keto-
sterol-26-monooxygenase that modifies 3-keto-sterols 
through successive side chain oxidation steps to gener-
ate DAF-12 ligands. The authors named these ligands 
∆4-dafachronic acid (for 3-keto-4-cholestenoic acid) 
and ∆7-dafachronic acid (for 3-keto-7,(5α)-cholestenoic 
acid), based on the dauer and heterochronic pheno-
types of daf-12 mutants.
Chemical synthesis of ∆4-dafachronic acid allowed 
Motola et al. (2006) to show that this compound can 
effectively activate DAF-12 in cotransfection assays and 
rescue daf-9 mutant phenotypes at nanomolar concen-
trations, demonstrating potent biological activity. Inter-
mediate concentrations of ∆4-dafachronic acid resulted 
in only a partial rescue of daf-9 phenotypes, suggesting 
that hormone levels are critical for DAF-12 function. In 
addition, ∆4-dafachronic acid had little effect on daf-12 
mutants that carry mutations predicted to affect ligand 
binding, consistent with the hormone directly regulat-
ing receptor activity. Consistent with classic models for 
nuclear receptor regulation, ∆4-dafachronic acid blocked 
the interaction between DAF-12 and its corepressor, 
DIN-1, and significantly enhanced the ability of DAF-12 
to recruit the mammalian coactivator SRC-1. This effect 
of ∆4-dafachronic acid on DAF-12 cofactor interactions 
also translated to DAF-12 activity, resulting in potent 
induction of a DAF-12-regulated luciferase reporter gene 
in cultured cells. Taken together, these studies suggest 
that ∆4-dafachronic acid directly binds to DAF-12 to influ-
ence its interactions with cofactors and thereby regulate 
its transcriptional activity. Binding to ∆4-dafachronic 
acid occurs with a high affinity characteristic of natu-
ral nuclear receptor ligands. Importantly, Motola et al. 
(2006) showed that 3-keto-cholestenoic acids could be 
isolated from extracts of wild-type worms, but not daf-9 
mutants, and that these molecules can activate DAF-12 
and fully rescue daf-9 mutants, defining them as natural 
hormones for DAF-12.
The identification of DAF-12 ligands enabled Motola 
et al. (2006) to determine the biological activity of 
dafachronic acid in the daf-2/insulin and daf-4/TGF-β 
pathways. ∆4-dafachronic acid rescued the phenotypes 
of both daf-7 and weak daf-2 mutants, in agreement with 
epistasis studies that position these genes upstream 
from daf-9 and daf-12 in the dauer pathway. Interest-
ingly, ∆4-dafachronic acid was unable to fully rescue a 
strong daf-2 mutant, suggesting that the insulin path-
way can also act downstream of, or parallel to, daf-12 
(Figures 1A and 1B), confirming genetic studies which 
indicate that daf-2 function is difficult to place relative 
to daf-12 (Riddle and Albert, 1997; Vowels and Thomas, 
1992). The requirement of 3-keto-sterols as DAF-9 pre-
cursors suggests that their synthesis may be an equally 
important regulatory step in the production of DAF-12 
ligands. The identification of enzymes responsible for 
converting cholesterol to a 3-keto-sterol thus represents 
an important future goal for our understanding of how 
DAF-12 ligands are produced.
Initial Insights into Dafachronic Acid Biosynthesis
Rottiers et al. (2006) report a first step in this direction 
by showing that daf-36 encodes a key component of 
the dafachronic acid biosynthetic pathway. The authors 
identified this gene in a screen for mutants that display 
heterochronic and Daf-c phenotypes similar to those 
of daf-9, reasoning that such genes might represent 
 additional steps in the DAF-9/DAF-12 pathway. Genetic 
studies positioned daf-36 downstream from TGF-β and 
insulin signaling and upstream from daf-12. Also, like 
daf-9, daf-36 mutations block the adult longevity asso-
ciated with germline ablation, clearly placing this gene in 
the signaling pathways that control reproductive devel-
opment and adult life span.daf-36 encodes a protein homologous to Rieske-like 
oxygenases found in plants, bacteria, and lower verte-
brates. Interestingly, a bacterial family member that is 
most similar in sequence to DAF-36 can catalyze the 
9-α hydroxylation of mammalian steroids, suggesting 
that DAF-36 may participate in the production of a DAF-
12 ligand. Consistent with this, ∆4-dafachronic acid can 
efficiently rescue daf-36 mutant phenotypes at concen-
trations similar to those required to rescue daf-9 mutants. 
Lathosterone and 4-cholesten-3-one could also rescue 
daf-36 mutants—two compounds that have no effect on 
daf-9 mutants—suggesting that daf-36 acts upstream 
from daf-9. Moreover, 7-dehydrocholesterol, but not its 
immediate precursor, cholesterol, could rescue daf-36 
mutants, suggesting that DAF-36 acts in the first step 
of dafachronic acid biosynthesis, modifying cholesterol 
to form 7-dehydrocholesterol (Figure 1A) or in a parallel 
pathway. These observations provide the first evidence 
that Rieske-like oxygenases can function in lipophilic 
hormone production. This proposal is consistent with 
the DAF-36 expression pattern, which is most abundant 
in the intestine—the major tissue for lipid storage in C. ­
elegans. Interestingly, DAF-36 is not detectable in the 
head ganglion cells that express DAF-9, suggesting that 
hormonal precursors from the intestine are modified by 
peripheral cells to produce functional dafachronic acid. 
DAF-36 expression in the intestine is also consistent with 
its role in controlling adult life span. daf-36 ­mutations 
block the increased life span of germline-deficient ani-
mals, suggesting that it contributes to DAF-9 and DAF-
12 endocrine signaling in the reproductive pathway.
Regulation of Life Span by Germline Signaling
Berman and Kenyon (2006) provide further insights into 
how hormone signaling from the reproductive system to 
the intestine can influence adult longevity. These authors 
identify a gene, kri-1, that is required for the extended 
life span due to germline ablation, and characterize 
the effects of kri-1, daf-9, and daf-12 mutations on this 
pathway. The kri-1 gene encodes a conserved protein 
with ankyrin repeats that is constitutively expressed in 
the pharynx and intestine throughout postembryonic 
stages. Like daf-9 and daf-12, kri-1 mutations suppress 
the increase in life span associated with germline loss 
but do not affect the life span of wild-type animals. In 
addition, kri-1 mutants have no significant effect on the 
life span of germline-deprived daf-2 mutants or on their 
Daf-c phenotype, indicating that kri-1 acts independently 
of DAF-2 in the reproductive-signaling pathway.
Upon germline ablation, DAF-16 in the intestine 
translocates from the cytoplasm to the nucleus, where 
its activity accounts for the entire increase in life span 
(Libina et al., 2003). By using a DAF-16::GFP fusion 
protein, Berman and Kenyon (2006) show that kri-1 is 
required for DAF-16 nuclear localization in the intestinal 
cells of germline-deficient animals. A less dramatic but 
significant reduction in nuclear DAF-16::GFP was also 
seen in daf-9 or daf-12 mutants. The nuclear localiza-
tion of DAF-16 seen in daf-2 mutants, however, is not Cell 124, March 24, 2006 ©2006 Elsevier Inc. 1139
affected by kri-1, daf-9, or daf-12 mutations. This indi-
cates that the roles of kri-1 and lipophilic hormone pro-
duction on DAF-16 nuclear localization are specific to 
the reproductive pathway and act largely independently 
of insulin signaling (Figure 1C).
The authors use a constitutively nuclear active DAF-16 
protein to perform epistasis tests with kri-1, daf-9, and 
daf-12 mutations to address the long-standing question 
of how DAF-9 and DAF-12 contribute to the longevity of 
germline-deficient animals. As expected, nuclear DAF-
16 extends the life span of daf-16 mutants that lack a 
germline. Similarly, nuclear DAF-16 rescues the increase 
in longevity seen upon germline ablation of kri-1 mutants, 
demonstrating that a key function for KRI-1 is to facilitate 
this localization of DAF-16 in the intestine. Interestingly, 
a daf-12 null mutation strongly blocked the longevity of 
germline-deficient animals that express nuclear DAF-16, 
indicating that DAF-12 can control longevity indepen-
dently of DAF-16. Even more remarkable, a strong daf-9 
allele has no effect on the longevity of germline-defi-
cient animals that express nuclear DAF-16, indicating 
that daf-9 acts upstream from DAF-16 and that DAF-12 
has functions in the germline-longevity pathway that are 
independent of lipophilic hormone signaling (Figure 1C). 
The identification of dafachronic-acid ligands for DAF-12 
provides new directions for these studies. It will be inter-
esting to determine how the hormone affects DAF-16 
nuclear localization and adult life span in both wild-type 
and mutant worms.
Perspectives
It is impressive that many of the predictions drawn from 
in vivo studies of daf-9 and daf-12 mutants are confirmed 
by the biochemical pathways outlined by Motola et al. 
(2006) and Rottiers et al. (2006)—yet more evidence 
of the elegance of C. ­elegans. Given the central role of 
DAF-12 in C. ­elegans biology, it is likely that the discovery 
of dafachronic-acid ligands for this receptor will have a 
major impact on the field. As Motola et al. (2006) men-
tion, the identification of two natural DAF-12 ligands sug-
gests that these hormones may have distinct biological 
functions. A critical first step for these studies will be the 
chemical synthesis of ∆7-dafachronic acid, which appears 
to be more efficacious and abundant in the animal than 
∆4-dafachronic acid. These ligands will facilitate more 
detailed functional characterization of DAF-9 and DAF-
12, as well as provide many future directions for study-
ing the critical decision between reproductive growth 
and dauer diapause and how the germline signals to the 
intestine to control adult longevity. The development of 
DAF-12 agonists and antagonists will provide invaluable 
tools for these studies, as well as a new basis for control-
ling parasitic nematodes, a major cause of crop damage 
and human disease in developing countries. In addition, 
further characterization of DAF-36 and the dafachronic 
acid biosynthetic pathway will provide critical insights 
into how hormone production is controlled to coordinate 
growth, maturation, and aging. Finally, these studies are 1140 Cell 124, March 24, 2006 ©2006 Elsevier Inc.not just about how nematodes develop but rather have 
wider implications. Endocrine circuits regulate progres-
sion through the life cycle and aging in all higher organ-
isms, from C. ­elegans up to humans (Pardee et al., 2004; 
Tatar et al., 2003). Recent studies in Drosophila have 
shown that both insulin and TGF-β signaling impact 
the activity of the EcR ecdysteroid receptor, control-
ling organismal growth and maturation (King-Jones and 
Thummel, 2005; Zheng et al., 2003). Similar signaling 
pathways play a central role in normal mammalian devel-
opment and human disease. It is likely that the break-
throughs described in these papers will have a major 
impact on our broader understanding of postembryonic 
development, providing a better basis for determining 
how endocrine signaling helps the animal complete its 
long and difficult journey through life.
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